Latest Articles
Pre-trial Rulings Define What Jurors Will Hear In Aaron Spencer Case Happy Mothers Day Message (FIK1pN8bUy) - Fathom Journal
Pre-trial Rulings Define What Jurors Will Hear In Aaron Spencer Case Happy Mothers Day Message (FIK1pN8bUy) Fathom Journal
Published: June 16, 2026, 11:06 a.m.
The Hon Patrick Gorman MP Television interview – ABC Afternoon Briefing - The National Tribune
The Hon Patrick Gorman MP Television interview – ABC Afternoon Briefing The National Tribune
Published: June 9, 2026, 2:17 a.m.
Infertility may pull menopause forward, study finds - Benefits and Pensions Monitor
Infertility may pull menopause forward, study finds Benefits and Pensions Monitor
Published: June 8, 2026, 12:33 p.m.
“World Breastfeeding” Week – Providing Advice For Mothers & Benefits For Babies - Bệnh viện FV
“World Breastfeeding” Week – Providing Advice For Mothers & Benefits For Babies Bệnh viện FV
Published: June 5, 2026, 6:31 p.m.
PhilHealth expands maternity, gynecologic care benefits - ABS-CBN
PhilHealth expands maternity, gynecologic care benefits ABS-CBN
Published: June 4, 2026, 9:10 a.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily
Published: June 3, 2026, 3:15 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - MSN
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer MSN
Published: June 2, 2026, 12:41 a.m.
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer - Medical Xpress
Addition of immunotherapy shows survival benefit in follow-up trial for primary advanced or recurrent endometrial cancer Medical Xpress
Published: June 1, 2026, 8 p.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive
Published: May 29, 2026, 11:57 p.m.
Link copied to clipboard!